More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders at ARS Pharmaceuticals, Crexendo, Emeren Group, and Kirkland's have recently made significant purchases of their companies' stocks. ARS Pharmaceuticals' director acquired 2.7 million shares for around $8.18 million, following the FDA's response to their New Drug Application. Crexendo's director bought 5,000 shares after the company posted positive Q2 results. Emeren Group's director purchased 437,258 shares after the company reported better-than-expected quarterly earnings. Kirkland's interim CEO bought 3,978 shares following weaker-than-expected Q2 FY23 results.
September 26, 2023 | 12:53 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Crexendo's director bought 5,000 shares after the company posted positive Q2 results.
Insider buying is often seen as a positive sign as it indicates that insiders believe in the company's prospects. The recent purchase by Crexendo's director could therefore be seen as a positive sign, especially given the company's positive Q2 results.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Kirkland's interim CEO bought 3,978 shares following weaker-than-expected Q2 FY23 results.
Insider buying is often seen as a positive sign as it indicates that insiders believe in the company's prospects. The recent purchase by Kirkland's interim CEO could therefore be seen as a positive sign, despite the company's weaker-than-expected Q2 FY23 results.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Emeren Group's director purchased 437,258 shares after the company reported better-than-expected quarterly earnings.
Insider buying is often seen as a positive sign as it indicates that insiders believe in the company's prospects. The recent purchase by Emeren Group's director could therefore be seen as a positive sign, especially given the company's better-than-expected quarterly earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
ARS Pharmaceuticals' director bought 2.7 million shares for around $8.18 million, following the FDA's response to their New Drug Application.
Insider buying is often seen as a positive sign as it indicates that insiders believe in the company's prospects. The recent purchase by ARS Pharmaceuticals' director could therefore be seen as a positive sign, especially given the recent FDA response to their New Drug Application.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100